\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationBrussels
Converging technologies, such as bio-, and nanotechnologies, engineering, digitalisation and big data have transformational power to drive research and innovation towards healthcare of the future. Prominent academics and policy makers will delve into compelling topics and technologies, and the potential of the different European partnerships and infrastructures during this two-day conference.
This Belgian presidency conference is coordinated by the Department for Economy, Science and Innovation of the Flemish government, in collaboration with the Research Department of the Public Service of Wallonia, the Department for Care of the Flemish government and Sciensano, and is co-financed by the Commission.
Initially, the event was communicated as on invitation only. As there are a few places left, it is opened to a broader range of stakeholders. You can register for the event here.
More information and the detailed programme is available on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
